UBS Downgrades Allstate to Neutral, Raises Price Target to $261
Benzinga Newsdesk 3 months ago
NewsDowngradesAnalyst RatingsPrice Target
UBS analyst Brian Meredith downgrades Allstate (NYSE:ALL) from Buy to Neutral and raises the price target from $255 to $261.
UBS analyst Brian Meredith downgrades Allstate (NYSE:ALL) from Buy to Neutral and raises the price target from $255 to $261.